致遠互聯(688369.SH):AI相關產品已逐步實現訂單轉化
格隆匯3月7日丨致遠互聯(688369.SH)在互動平臺表示,目前,公司發佈了五大類AI產品和服務,包括知識服務類、內容創作類、數據分析類、流程自動化類和對話服務類,以及AI原生應用。AI相關產品已逐步實現訂單轉化。面對客戶的AI新增需求,不同規模客戶的需求特點不同,市場空間會因AI需求帶來的預算增長而變大。公司通過強大業務中臺能力和AI能力形成智能化系統平臺,採用平臺加端模式,滿足客戶長尾管理需求。公司將繼續堅定“AI和信創”戰略,積極投入AI產品研發,持續深化“AI+場景”融合,爲企業客戶提供一體化解決方案,賦能企業實現“智能化協同運營”。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.